BREAKING NEWS APRIL 15, 2026 - In a welcome announcement to the SSRP community, the FDA reported today that it will imminently remove the following bulk drug substances from category 2: BPC-157, LL-37, DiHexa, DSIP, Epitalon, *GHK-Cu (injectable only), KPV, PEG-MGF, Melanotan II, MOTs-C, Semax, and TB-500
Palm R, Wahlstrom G, Hallmans G
Frequently Asked Questions How do you reconstitute retatrutide
Follow Fox News Digitals sports coverage on X and subscribe to the Fox News Sports Huddle newsletter .
For wellness clinic founders, medical spa directors, and healthcare entrepreneurs, stocking or administering unapproved peptides is no longer a minor regulatory gray area